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Abstract 
Purpose: To evaluate the in vitro antioxidant and anti-neuroinflammatory activities of Inula helenium 
extract (IHE) against lipopolysaccharide (LPS)-induced production of nitric oxide (NO) by primary 
microglial cells. 
Methods: Cell viability was estimated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyl-tetrazolium bromide 
(MTT) assay. Antioxidant activity was evaluated using 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical 
scavenging assay. LPS-stimulated BV-2 microglia were used to study the expression and production of 
inflammatory mediators, including NO, inducible NO synthase (iNOS) and Interukin-6 (IL-6).  
Results: Pretreatment with IHE prior to LPS treatment significantly inhibited excessive production of NO 
(p < 0.001 at 20, 40, 80 and 100 μg/mL) in a dose-dependent manner, and was associated with down-
regulation of expression of inducible nitric oxide synthase (iNOS). IHE also suppressed the LPS-
induced increase in IL-6 level (p < 0.01 at 40 and 80 μg/mL) in BV-2 cells. The antioxidant activity 
exhibited by IHE might play a critical role in ameliorating neuroinflammatory processes in LPS-
stimulated BV-2 microglial cells. 
Conclusion: IHE may be beneficial in preventing and treating neurodegenerative and oxidative stress-
related diseases. 
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Inula helenium, also known as elecampane, is 
commonly found in China. In traditional medicine, 
it is extensively used primarily for treatment of 
abdominal pain, emesis, diarrhea, and 
threatened abortion [1]. In addition, the roots are 
effective in the treatment of diuretic, diaphoretic, 
expectorant, and anthelmintic remedy [2]. I. 
helenium has been identified that I. helenium 
contains sesquiterpene lactones and flavonoids 
[3–7], while other studies have reported that 
phenolic compounds exist in the Compositae [8]. 
However, till date, the effect of I. helenium 
extract on microglia-mediated neuroinflammatory 
diseases has not been reported. 
 
Microglia are the resident macrophage-like cells 
of the central nervous system (CNS) with a broad 
role in the brains innate immunity and in 
inflammatory neuro-pathologies [9]. They are 
highly responsive to stress and injury and 
become immediately and focally activated in 
response to Alzheimer’s disease (AD), 
Parkinson’s disease (PD), multiple sclerosis 
(MS), and amyotrophic lateral sclerosis (ALS) 
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[10,11]. Microglia are involved in initiating 
inflammatory responses in the brain through 
secreting a variety of inflammatory mediators, 
including nitric oxide (NO), inducible NO 
synthase (iNOS), interleukins (IL) and tumor 
necrosis factor (TNF)-α [11]. Thus, modulation of 
activated microglia is an effective strategy for 
therapeutics in the neuro-inflammation. 
 
The most common cause of inflammatory 
responses is an exposure to lipopolysaccharide 
(LPS), a component of the outer membrane of 
Gram-negative bacteria [12]. LPS-activated BV-2 
microglia cells responses induction and secretion 
of pro-inflammatory mediators. Therefore, 
suppression of aberrant activation of BV-2 
microglia cells may have valuable therapeutic 
potential for the treatment of inflammatory 
diseases such as AD and PD [13].  
 
In this study, we investigated the effects of I. 
helenium on the NO production, expression of 
iNOS, and pro-inflammatory cytokines from LPS-
stimulated BV-2 microglia cells. The findings 
show that I. helenium may be used for the 





Preparation of Inula helenium extract (IHE)  
 
Inula helenium collected at the end of June to 
about the middle of August were obtained from 
the local market, Seoul, South Korea. Inula 
helenium was washed in running tap water, dried 
at 60 °C for 24 h and then ground to fine powder. 
Each powder was extracted with 10 volumes 
(v/w) of 70 % ethanol at a room temperature for 
72 h and filtrated. The filtered extract was 
concentrated by a rotary evaporator (EYELA 
NVC-2000, Tokyo, Japan) under reduced 
pressure and lyophilized (Jeol Ltd, Tokyo, 
Japan). 
 
DPPH radical scavenging activity  
 
This assay was based on the scavenging of 
stable 2, 2-diphenyl-1-picrylhydrazyl (DPPH, 
Sigma-Aldrich, St Louis, MO, USA) radicals by 
the radical scavenging antioxidants in IHE. The 
radical scavenging capacity was evaluated by 
employing a reaction mixture constituted by 
aliquots of the IHE and a DPPH methanolic 
solution as described previously [14]. Briefly, a 
sample solution of 60 μl of each IHE, was added 
to 60 μl of DPPH (60 μM) in methanol. After 
mixing vigorously for 10 s, the mixture was 
transferred into a 100 µL Teflon capillary tube 
and the scavenging activity of each sample on 
DPPH radical was measured using a JES-FA 
ESR spectrometer (Jeol Ltd., Tokyo, Japan). A 
spin adduct was measured on an ESR 
spectrometer exactly after 2 min. Experimental 
conditions were as follows: central field, 3,475 G; 
modulation frequency, 100 kHz; modulation 
amplitude, 2 G; microwave power, 5 mW; gain, 
6.3 x 105, and temperature, 298 °K. 
 
Cell cultures and viability 
 
BV-2 microglia cells were grown in RPMI1640 
(Invitrogen, Carlsbad, CA, USA), supplemented 
with 10 % FBS (Hyclone, Logan, UT, USA)  
containing 100 U/ml of penicillin (Invitrogen), and 
100 μg/mL streptomycin (Invitrogen)  in 37 °C in 
humidified atmosphere of 5 % CO2. In all 
experiments, cells were pre-treated with the 
indicated concentrations of IHE for 1 h before the 
addition of LPS (1 µg/ml, Sigma-Aldrich, St. 
Louis, MO, USA) in serum free RPMI1640. An 
equal volume of IHErile water was added to all 
control treatments. Cell viability was determined 
by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) assay as 
described previously [15]. Cells were incubated 
with various concentrations of IHE for 24 h 
followed by MTT for 4 h, and then 100 μL of 
isopropanol (in 0.04 N-hydrochloric acid) was 
added to dissolve the formazan crystals. The 
absorbance was read at 570 nm using the 
Anthos 2010 spectrophotometer (Salzburg, 
Austria). Cell viability was calculated as relative 
absorbance compared to control. 
 
Nitric oxide assay 
 
The amount of NO production in the medium was 
detected with the Griess reaction [16]. Each 
supernatant was mixed with the same volume of 
Griess reagent (1 % sulfanilamide in 5 % 
phosphoric acid and 0.1 % naphthyl 
ethylenediamine dihydrochloride in water). The 
absorbance of the mixture at 540 nm was 
determined with an ELISA reader (Bio-Tek 
Instrument, Winooski, VT, USA), nitrite 
concentration was determined using sodium 




BV-2 cells were lysed in a buffer containing 20 
mM Tris‐HCl, pH 7.5, 150 mM NaCl, 1 mM 
EDTA, 50 mM β‐glycerophosphate, 1 % NP‐40, 
1 mM Na3VO4 and 1 X protease inhibitor cocktail 
(Complete MiniTM, Roche, Mannheim, 
Germany). The lysates were centrifuged at 
15,000 x g for 15 min and supernatants were 
collected. The concentrations of protein samples 
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were measured using the BCA reagent (Pierce, 
Rockford, IL, USA). The protein was separated 
by sodium dodecylsulphate (SDS) 
polyacrylamide gel electrophoresis (PAGE) and 
transferred to PVDF membranes. After blocking 
with 5 % non‐fat milk, the membranes were 
hybridized with 1:1000 dilution of primary 
antibodies for iNOS and β-actin for 12 h at 4 °C. 
Membranes were washed with Tris‐Buffered 
Saline containing 0.1 % Tween‐20 (TBST) three 
times with 5 min interval and hybridized with 
horseradish peroxidase‐conjugated mouse or 
rabbit secondary antibodies for 1 h at room 
temperature. After washing three times with 
TBST, antigen‐antibody complexes were 
visualized with an ECL Western Blot Detection 
Kit (GE Healthcare) according to the 
manufacturer’s instructions. The antibodies 
against iNOS and β-actin were purchased from 





BV-2 microglia cells (1 x 105 cells/well) were 
cultured on 96 well plates and treated with the 
IHE at indicated concentrations for 1 h  and 
stimulated with LPS (1 µg/ml). At 24 h post-LPS 
treatment, the production of IL-6 was determined 
in cell supernatant using assay kits (BD 
Biosciences, San Jose, CA, USA) as per the 
manufacturer’s instructions. The IL-6 assay was 
performed at 20 °C and optical absorbance was 




All data are presented as the mean ± SEM (n = 
3). Statistical analyses were performed using 
SAS statistical software (SAS Institute, Cray, NC, 
USA) using one-way analysis of variance, 
followed by Dunnett's multiple range tests.           




Effect of IHE on DPPH radical scavenging 
activity  
 
As shown in Fig 1A, IHE exhibited significant 
DPPH radical scavenging activity in a dose-
dependent manner showing a maximum effect at 
1 mg/mL of concentration. The ESR 
spectroscopy data at 0.1, 1, 10, 100 and 1000 
µg/mL is represented in Fig 1B. 
 
Effect of IHE on LPS-induced NO production 
IHE treatment did not exhibit any significant 
cytotoxicity in BV-2 microglial cells treated for 24 
h at concentrations up to 200 µg/ml, and in all 
cases the viability was found above 96 % by 
MTT assay (Fig 2).  As shown in Fig 3, treatment 
of LPS resulted in the excessive production of  
 
 
Figure 1: Effect of IHE on DPPH radical scavenging activity. The capacity to scavenge DPPH free radical by 
different concentrations IHE (A) and ESR spectra (B) was measured. BV-2 cells were treated with or without IHE 
at the various concentrations (0.1, 1, 10, 100, and 1000 μg/mL). The scavenging activity of each sample on 
DPPH radical was measured using a JES-FA ESR spectrometer. A spin adduct was measured on an ESR 
spectrometer exactly 2 min later. IHE: Inula helenium ethanol extract 
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Figure 2: Effects of IHE on the viability of BV-2 microglial cells. Viability in IHE-treated cells was determined 
using MTT assay. The results are displayed in percentage of control samples. Data are presented as mean ± 
SEM (n = 3) for three independent experiments. ns Not significant; IHE = Inula helenium ethanol extract 
 
 
Figure 3: Effect of IHE on NO Production in LPS-stimulated BV-2 microglial cells. BV-2 cells were treated with 
IHE at various concentrations (10, 20, 80, and 100 µg/mL) with or without LPS (1 µg/mL) for 24 h. The nitrite in 
the culture supernatant was evaluated using Griess reagent. Data are presented as mean ± SEM (n = 3) for three 
independent experiments. #p < 0.001, when compared with control group. *p < 0.05, **p < 0.01 and ***p < 0.001, 
when compared with LPS alone treated group by one-way analysis of variance, followed by Dunnett's multiple 
range tests; IHE: Inula helenium ethanol extract 
 
NO. Pretreatment of IHE significantly suppressed 
the LPS-induced NO production in a 
concentration-dependent manner (Fig 2). The 
maximum effect was shown at 100 µg/mL (p < 
0.001). 
 
Effect of IHE on LPS-induced expressional 
levels of iNOS 
 
Western blot analysis showed that the protein 
expression of iNOS in the LPS-stimulated BV-2 
cells was also suppressed in a concentration 
dependent manner. However, treatment with IHE 
exhibited a broad spectrum of inhibitory effect on 
the expression of iNOS induced by LPS in BV-2 
cells (Fig 4). 
 
Effect of IHE on IL-6 production in LPS-
stimulated BV-2 cells  
 
As shown in Fig. 5, IL-6 levels increased 
significantly after LPS treatment (1 µg/ml) when 
compared to those in untreated cells (p < 0.001). 
However, IHE significantly inhibited IL-6 
 
- +    +    +   +







Figure 4: Effect of IHE on iNOS protein expressional 
levels in LPS-stimulated BV-2 microglial cells. The 
expression levels of iNOS production in the LPS-
stimulated BV-2 cells by indicated concentrations (50, 
100 and 150 µg/mL) of the IHE was monitored by 
immunoblot analyses with the specific antibodies 
against iNOS. The internal control used was β-actin. 
IHE: Inula helenium ethanol extract; LPS = 
lipopolysaccharide; iNOS = inducible nitric oxide 
synthase 
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Figure 5: Effect of IHE on IL-6 production in LPS-stimulated BV-2 microglial cells. Suppression of pro-
inflammatory cytokine IL-6 expression by IHE was measured with ELISA test. BV-2 cells were treated with IHE at 
20, 40 and 80 µg/mL with or without LPS (1 µg/ml) for 24 h. The IL-6 in the culture supernatant was evaluated 
using a murine IL-6 ELISA kit. Data are presented as mean ± SEM (n = 3) for three independent experiments. #p 
< 0.001, when compared with control group. *p < 0.05, and **p < 0.01, ***p < 0.001 when compared with LPS 
alone group by Student t-test. IHE = Inula helenium ethanol extract; IL-6: Interukin-6; LPS = lipopolysaccharide) 
 
production in a concentration-dependent manner 
in LPS-stimulated BV-2 cells (p < 0.05 at 20 





The present study demonstrated that IHE 
possesses an anti-neuroinflammatory activity in 
LPS-stimulated BV-2 microglia cells and 
antioxidant activity. IHE also exhibited significant 
antioxidant activity. Free radicals and reactive 
oxygen species (ROS) are important causative 
factors in the development of age-related 
neuroinflammatory and neurodegenerative 
diseases [14]. Thus neutralization by antioxidants 
and radical scavengers can reduce 
neuroinflammation. It is well known that DPPH 
radical assay as one of the widely used methods 
for evaluating the free radical scavenging 
activities of several antioxidants in a relatively 
short period of time [16]. In our present study, 
IHE also exhibited significant free radical 
scavenging effect indicating that it might contain 
potential antioxidant agents. In our present study, 
the IHE exhibited significant free radical 
scavenging effect indicating that the Inula 
helenium might contain potential antioxidant 
agents. 
 
In BV-2 microglia cells, NO is generated by the 
inducible isoform of NO synthase (iNOS) and 
iNOS are responsible for the symptoms of many 
neuro-inflammatory diseases [16]. Thus, high 
levels of NO are produced from L-arginine by 
iNOS in the brain by prolonged activation of 
microglial cells, and this response is associated 
with the progression of various 
neurodegenerative diseases [17]. Our results 
clearly showed that IHE attenuated LPS-induced 
iNOS expression and downstream NO 
production. This result indicates that IHE acts 
principally by regulating NO generation at the 
post-transcriptional level and could be beneficial 
for preventing the progression of neuro-
inflammation by BV-2 microglial activation. Pro-
inflammatory cytokines such as TNF-α are the 
initiators of the inflammatory response and the 
mediators of the development of chronic 
inflammatory diseases [18]. Therefore, the over-
production of pro-inflammatory cytokines by 
activated microglia cell is a possible etiological 
factor of neurological disorders [19].  Microglial 
cell activation by LPS produces various cytokines 
including IL-6 leading to the attraction of 
neutrophils and the accumulation of neutrophil-
secreted proteases and ROS at the site of 
inflammation. From our results, it appears that 
IHE may act by suppressing the expression of IL-
6 protein levels and thereby inhibiting NO 
production and iNOS expression levels in LPS-




These data demonstrate that IHE has anti-
inflammatory properties in LPS-induced BV-2 
microglial activation through the down-regulation 
of inflammation-related gene expression, 
including iNOS and pro-inflammatory cytokine 
such as IL-6. Therefore, IHE can be considered 
as a useful therapeutic and preventive approach 
for the treatment of several neurodegenerative 
and oxidative stress-related diseases. 
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